LekoskopLekoskop
EN All changes
Medicine recalls and shortages › New approvals › 2 Dec 2025
MHRA approval

tisotumab vedotin

Published on 2 Dec 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
MHRA announcement ↗ All events: tisotumab vedotin

What this means

The MHRA has announced the approval of a medicine or a new indication in the UK. Approval does not mean the product is already available on the NHS: NICE appraisal and commissioning may follow.

Summary

As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.